Sinopharm Group (01093.HK): Li Chunlei appointed as authorized representative

Wisdom Financial News APP News, SinoPharm Group (01093.HK) announced that, effective from November 4, 2025, Mr. Pan Weidong has resigned as an executive director of the company and will no longer serve as the authorized representative of the company under Rule 3.05 of the Hong Kong Stock Exchange Listing Rules due to needing more time to deal with his personal affairs; Dr. Li Chunlei, an executive director of the company, has been appointed as the authorized representative.